Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2021

Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,152 recalls, newest first.

Class II · Moderate risk

Rompe Pecho DM

Microbial Contamination of Non-Sterile Products

Terminated Microbial contamination Efficient Laboratories, Inc. NDC 58593-275-06 D-0291-2022
Class II · Moderate risk

Betamethasone Dipropionate Lotion USP

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-023-29 D-0297-2022
Class II · Moderate risk

Strophanthus hisp 30X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0890-2021
Class II · Moderate risk

Strophanthus hisp 30X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0889-2021
Class II · Moderate risk

ZTE 1015 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0888-2021
Class II · Moderate risk

ZTE-1035 Formula

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0886-2021
Class II · Moderate risk

Viola od 6X

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0878-2021
Class II · Moderate risk

Quebracho 4C

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Terminated Failed specification Washington Homeopathic Products, Inc. D-0877-2021

Recalls by year